申请人:——
公开号:US20030069290A1
公开(公告)日:2003-04-10
The invention provides compounds of Formula I: compounds of the Formula I:
1
wherein R
1
, R
2
, R
4
, R
6
, X, and W are defined herein. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which &agr;7 is known to be involved.
该发明提供了Formula I的化合物:Formula I的化合物:其中R1、R2、R4、R6、X和W在此处被定义。这些化合物可以是药用盐或组合物的形式,可以是纯对映体形式或混合物,对于治疗已知涉及α7的疾病或病况的药物是有用的。